MedWatch

Oncology Venture to add four new projects to its pipeline

Danish biotech company Oncology Venture has secured million-dollar funding and the chance to add four new drug development projects to its pipeline. Meanwhile, it has launched a new US company that could eventually go public.

Foto: Krabbe Lars, Jyllands-Posten

Management in the Danish biotech company Oncology Venture had a busy end to 2016. Before the turn of the year, the company secured the option to bring four new candidate products into its pipeline, three in the US and one in Denmark. Meanwhile, it has also secured non-dilutive financing of USD 4 million for these projects.

Oncology Venture has established a search team of hematologists and oncologists to hunt for possible candidate drugs, and it also has one employee based in Boston who has negotiated with US-based corporations for the new candidates, two of which have been acquired from Big Pharma players.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier